A study for a 64 year old woman who takes Zyrtec, Restasis, Myrbetriq, Omega 3, Multivitamin, Celecoxib - from FDA reports


Summary

5 females aged 64 (±5) who take the same drugs are studied. This is a personalized study for a 64 year old female patient who has Seasonal Allergy, Incontinence, Oa, General Health, Dry Eye. The study is created by eHealthMe based on reports from FDA.

Personalized health information

On eHealthMe you can find out what patients like me (same gender, age) reported their drugs and conditions on FDA since 1977. Our tools are simple to use, anonymous and free. Start now >>>


On Nov, 01, 2017

5 females aged 64 (±5) who take Zyrtec, Restasis, Myrbetriq, Omega 3, Multivitamin, Celecoxib are studied.


Number of reports submitted per year:

Zyrtec, Restasis, Myrbetriq, Omega 3, Multivitamin, Celecoxib for a 64-year old woman.

Information of the patient in this study:

  • Age: 64
  • Gender: female
  • Conditions: Seasonal Allergy, Incontinence, Oa, General Health, Dry Eye
  • Drugs taken:
    • Zyrtec (cetirizine hydrochloride)
    • Restasis (cyclosporine)
    • Myrbetriq (mirabegron)
    • Omega 3 (cod liver oil)
    • Multivitamin (ascorbic acid; biotin; cyanocobalamin; dexpanthenol; ergocalciferol; folic acid; niacinamide; pyridoxine hydrochloride; riboflavin phosphate sodium; thiamine hydrochloride; vitamin a; vitamin e)
    • Celecoxib (celecoxib)

eHealthMe real world results:

Most common drug interactions over time

< 1 month:
  • iliotibial band syndrome
  • malaise
1 - 6 months:
n/a
6 - 12 months:
n/a
1 - 2 years:
n/a
2 - 5 years:
n/a
5 - 10 years:
n/a
10+ years:
n/a
not specified:
  • weakness
  • colitis ischaemic
  • injection site haemorrhage
  • bleeding disorders
  • narcolepsy
  • injection site mass
  • lactic acidosis
  • aspartate aminotransferase increased
  • iliotibial band syndrome
  • sepsis

Top conditions involved for these people *:

  • Narcolepsy (2 people, 40.00%)
  • Psoriatic Arthropathy (1 person, 20.00%)
  • Drowsiness (1 person, 20.00%)
  • Constipation (1 person, 20.00%)

Top co-used drugs for these people *:

  • Vitamin D (3 people, 60.00%)
  • Xyrem (2 people, 40.00%)
  • Synthroid (2 people, 40.00%)
  • Claritin (2 people, 40.00%)
  • Calcium (2 people, 40.00%)

* Some reports may have incomplete information.

How to use the study: print a copy of the study and bring it to your health teams to ensure drug risks and benefits are fully discussed and understood.

Subscribe to the study: get notified of updates to the study.

Want to find out more about the FDA reports used in the study? You can request them from FDA.

You can also:

Expand the study to include reports from both FDA and eHealthMe

Expand this study to include FDA and eHealthMe reports

What are the drugs?

What are the conditions?

Related studies:

Can you answer these questions?

More questions for: Incontinence, Zyrtec, Dry eye, Myrbetriq, Oa, Restasis, Seasonal allergy, Omega 3, Multivitamin, General health, Celecoxib

You may be interested in these reviews

More reviews for: Incontinence, Zyrtec, Dry eye, Myrbetriq, Oa, Restasis, Seasonal allergy, Omega 3, Multivitamin, General health, Celecoxib